Schneeweiss A - Search Results

1

CATCH: A Prospective Precision Oncology Trial in Metastatic Breast Cancer.

Hlevnjak M, Schulze M, Elgaafary S, Fremd C, Michel L, Beck K, Pfütze K, Richter D, Wolf S, Horak P, Kreutzfeldt S, Pixberg C, Hutter B, Ishaque N, Hirsch S, Gieldon L, Stenzinger A, Springfeld C, Smetanay K, Seitz J, Mavratzas A, Brors B, Kirsten R, Schuetz F, Fröhling S, Sinn HP, Jäger D, Thewes V, Zapatka M, Lichter P, Schneeweiss A. Hlevnjak M, et al. Among authors: schneeweiss a. JCO Precis Oncol. 2021 Apr 22;5:PO.20.00248. doi: 10.1200/PO.20.00248. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34036222 Free PMC article.

2

Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer.

Huober J, Schneeweiss A, Hohaus S, Wittmann G, Meyer A, Martin S, Goldschmidt H, Bastert G, Haas R, Wallwiener D. Huober J, et al. Among authors: schneeweiss a. J Cancer Res Clin Oncol. 1998;124(12):690-4. doi: 10.1007/s004320050233. J Cancer Res Clin Oncol. 1998. PMID: 9879830 Clinical Trial.

3

Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support.

Hensel M, Schneeweiss A, Sinn HP, Egerer G, Kornacker M, Solomayer E, Haas R, Bastert G, Ho AD. Hensel M, et al. Among authors: schneeweiss a. Stem Cells. 2002;20(1):32-40. doi: 10.1634/stemcells.20-1-32. Stem Cells. 2002. PMID: 11796920

4

P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support.

Hensel M, Schneeweiss A, Sinn HP, Egerer G, Solomayer E, Haas R, Bastert G, Ho AD. Hensel M, et al. Among authors: schneeweiss a. Int J Cancer. 2002 Jul 20;100(3):290-6. doi: 10.1002/ijc.10478. Int J Cancer. 2002. PMID: 12115543

5

Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression.

Schneeweiss A, Sinn HP, Ehemann V, Khbeis T, Neben K, Krause U, Ho AD, Bastert G, Krämer A. Schneeweiss A, et al. Int J Cancer. 2003 Nov 10;107(3):346-52. doi: 10.1002/ijc.11408. Int J Cancer. 2003. PMID: 14506732

6

Only grading has independent impact on breast cancer survival after adjustment for pathological response to preoperative chemotherapy.

Schneeweiss A, Katretchko J, Sinn HP, Unnebrink K, Rudlowski C, Geberth M, Beldermann F, Bastert G, Strittmatter HJ. Schneeweiss A, et al. Anticancer Drugs. 2004 Feb;15(2):127-35. doi: 10.1097/00001813-200402000-00005. Anticancer Drugs. 2004. PMID: 15075668

7

Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapy.

Schneeweiss A, Diel I, Hensel M, Kaul S, Sinn HP, Unnebrink K, Rudlowski C, Lauschner I, Schuetz F, Egerer G, Haas R, Ho AD, Bastert G. Schneeweiss A, et al. Ann Oncol. 2004 Nov;15(11):1627-32. doi: 10.1093/annonc/mdh433. Ann Oncol. 2004. PMID: 15520063 Free article.

8

Neoadjuvant therapy with gemcitabine in breast cancer.

Schneeweiss A, Bastert G, Huober J, Wallwiener D, Hamerla R, Lichter P. Schneeweiss A, et al. Oncology (Williston Park). 2004 Dec;18(14 Suppl 12):27-31. Oncology (Williston Park). 2004. PMID: 15685823 Free article. Clinical Trial.

9

Dose-dense primary systemic chemotherapy with gemcitabine plus epirubicin sequentially followed by docetaxel for early breast cancer: final results of a phase I/II trial.

Schneeweiss A, Schuetz F, Rudlowski C, Hahn M, Lauschner I, Sinn HP, von Fournier D, Sohn C. Schneeweiss A, et al. Anticancer Drugs. 2005 Oct;16(9):1023-8. doi: 10.1097/01.cad.0000176508.73090.fb. Anticancer Drugs. 2005. PMID: 16162980 Clinical Trial.

10

Prognostic factors for patients with liver metastases from breast cancer.

Eichbaum MH, Kaltwasser M, Bruckner T, de Rossi TM, Schneeweiss A, Sohn C. Eichbaum MH, et al. Among authors: schneeweiss a. Breast Cancer Res Treat. 2006 Mar;96(1):53-62. doi: 10.1007/s10549-005-9039-1. Breast Cancer Res Treat. 2006. PMID: 16319993

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

678 results

Search Page

Filters